These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29718108)

  • 1. The anti-epileptic drug lamotrigine inhibits the CYP17A1 lyase reaction in vitro.
    Munkboel CH; Christensen LR; Islin J; Bonomo S; Olsen L; Jørgensen FS; Styrishave B
    Biol Reprod; 2018 Oct; 99(4):888-897. PubMed ID: 29718108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the unique benzodiazepine structure interacting with CYP enzymes to affect steroid synthesis in vitro?
    Johannsen ML; Munkboel CH; Jørgensen FS; Styrishave B
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105765. PubMed ID: 32991989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax.
    Munkboel CH; Rasmussen TB; Elgaard C; Olesen MK; Kretschmann AC; Styrishave B
    Toxicology; 2019 Sep; 425():152247. PubMed ID: 31330226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective endocrine disrupting effects of omeprazole studied in the H295R cell assay and by molecular modeling.
    Sørensen AM; Hansen CH; Bonomo S; Olsen L; Jørgensen FS; Weisser JJ; Kretschmann AC; Styrishave B
    Toxicol In Vitro; 2016 Aug; 34():71-80. PubMed ID: 27002602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The steroid metabolite 16(β)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1.
    Neunzig J; Milhim M; Schiffer L; Khatri Y; Zapp J; Sánchez-Guijo A; Hartmann MF; Wudy SA; Bernhardt R
    J Steroid Biochem Mol Biol; 2017 Mar; 167():182-191. PubMed ID: 28065637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A disrupts steroidogenesis in human H295R cells.
    Zhang X; Chang H; Wiseman S; He Y; Higley E; Jones P; Wong CK; Al-Khedhairy A; Giesy JP; Hecker M
    Toxicol Sci; 2011 Jun; 121(2):320-7. PubMed ID: 21427057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Folpet, Captan, and Captafol on Human Aromatase in JEG-3 Cells.
    Ge H; Chen L; Su Y; Jin C; Ge RS
    Pharmacology; 2018; 102(1-2):81-87. PubMed ID: 29953993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards an Understanding of the Mode of Action of Human Aromatase Activity for Azoles through Quantum Chemical Descriptors-Based Regression and Structure Activity Relationship Modeling Analysis.
    Chayawan C; Toma C; Benfenati E; Caballero Alfonso AY
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
    Islin J; Munkboel CH; Styrishave B
    Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway.
    Rodríguez Castaño P; Parween S; Pandey AV
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of endocrine disrupting chemicals acting on human aromatase.
    Baravalle R; Ciaramella A; Baj F; Di Nardo G; Gilardi G
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):88-96. PubMed ID: 28578073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations.
    Sgrignani J; Cavalli A; Colombo G; Magistrato A
    Mini Rev Med Chem; 2016; 16(14):1112-24. PubMed ID: 27337972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells.
    Lundqvist J; Norlin M; Wikvall K
    Biochim Biophys Acta; 2010 Sep; 1801(9):1056-62. PubMed ID: 20420936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
    Takahashi M; Yamashita K; Numazawa M
    Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
    Malikova J; Brixius-Anderko S; Udhane SS; Parween S; Dick B; Bernhardt R; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Nov; 174():192-200. PubMed ID: 28893623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.
    Petrunak EM; Rogers SA; Aubé J; Scott EE
    Drug Metab Dispos; 2017 Jun; 45(6):635-645. PubMed ID: 28373265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-Carbon Bond Cleaving Cytochrome P450 Enzymes: CYP17A1, CYP19A1 and CYP51A1.
    Akhtar M; Wright JN
    Adv Exp Med Biol; 2015; 851():107-30. PubMed ID: 26002733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics and Mechanism of Binding of Androstenedione to Membrane-Associated Aromatase.
    Paço L; Zarate-Perez F; Clouser AF; Atkins WM; Hackett JC
    Biochemistry; 2020 Aug; 59(33):2999-3009. PubMed ID: 32786398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors.
    Gumede NJ; Nxumalo W; Bisetty K; Escuder Gilabert L; Medina-Hernandez MJ; Sagrado S
    Bioorg Chem; 2020 Jan; 94():103462. PubMed ID: 31818479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production.
    Hecker M; Newsted JL; Murphy MB; Higley EB; Jones PD; Wu R; Giesy JP
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):114-24. PubMed ID: 16962624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.